Follow The Filings

DX Dynex Capital REIT

Real Estate, filed as DYNEX CAPITAL REIT ORD (EQUITY), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by DX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DX insider trades
  • $269K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Byron L Boston CEO
    Buy
    $100K 9,180 shares at $10.89 +1% to stake
    Traded Oct 20 Filed Oct 21
    ↗
  2. Smriti Laxman Popenoe CEO
    Buy
    $106K 10,000 shares at $10.62 +1.9% to stake
    Traded Oct 20 Filed Oct 20
    ↗
  3. Michael Andrew Sartori CFO
    Buy
    $11K 1,000 shares at $10.70 +2.8% to stake
    Traded Oct 20 Filed Oct 20
    ↗
  4. Terrence John Connelly Jr. Chief Investment Officer
    Buy
    $28K 2,500 shares at $11.18 +4.4% to stake
    Traded Sep 25 Filed Sep 28
    ↗
  5. Smriti Laxman Popenoe CEO
    Buy
    $24K 2,000 shares at $12.19 +0.4% to stake
    Traded Feb 27 Filed Mar 30
    ↗

Also filed in the last 12 months, not counted as buying or selling: 11 stock grants, 9 share withholdings for taxes, and 1 trade in other securities.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 3.03,5.03,8.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.02,5.03,5.07,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$6.13M $113.9M $319.07M

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $6.37B $8.18B $17.34B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $62.2M $14.39M $120.82M
Cash from investing -$2.96B -$1.03B -$8.07B
Cash from financing $2.69B $1.4B $8.26B
Net change in cash * -$212.01M $383.68M $308.85M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.